AE11517
Packsize | Purity | Availability | Price | Discounted Price | Quantity | |
---|---|---|---|---|---|---|
1mg | 98% | in stock | $25.00 | $17.00 | - + | |
5mg | 98% | in stock | $58.00 | $40.00 | - + | |
10mg | 98% | in stock | $92.00 | $64.00 | - + | |
25mg | 98% | in stock | $185.00 | $129.00 | - + | |
50mg | 98% | in stock | $310.00 | $217.00 | - + | |
100mg | 98% | in stock | $405.00 | $283.00 | - + | |
250mg | 98% | in stock | $628.00 | $439.00 | - + | |
1g | 98% | in stock | $1,695.00 | $1,186.00 | - + |
*All products are for research use only and not intended for human or animal use.
*All prices are in USD.
Catalog Number: | AE11517 |
Chemical Name: | Bexagliflozin |
CAS Number: | 1118567-05-7 |
Molecular Formula: | C24H29ClO7 |
Molecular Weight: | 464.9358599999998 |
MDL Number: | MFCD28100944 |
SMILES: | OC[C@H]1O[C@@H](c2ccc(c(c2)Cc2ccc(cc2)OCCOC2CC2)Cl)[C@@H]([C@H]([C@@H]1O)O)O |
Bexagliflozin, a potent and selective sodium-glucose cotransporter 2 (SGLT2) inhibitor, has gained significant attention in the field of chemical synthesis. With its unique pharmacophore and high affinity for the SGLT2 receptor, Bexagliflozin serves as a valuable tool in the development of novel drug candidates targeting diabetes and related metabolic disorders.In chemical synthesis, Bexagliflozin can be utilized as a key building block or starting material for the preparation of structurally diverse molecules. Its well-defined structure and known reactivity make it an ideal substrate for synthetic manipulations, such as functional group transformations, cross-coupling reactions, and heterocycle formation. By leveraging the specific interactions of Bexagliflozin with the SGLT2 receptor, researchers can design and synthesize analogs with improved biological activity, selectivity, and pharmacokinetic properties.Furthermore, the incorporation of Bexagliflozin into multistep synthetic sequences allows for the efficient assembly of complex molecular scaffolds, facilitating the exploration of new chemical space and the identification of lead compounds for drug discovery efforts. By harnessing the synthetic versatility of Bexagliflozin, chemists can expedite the development of innovative therapeutic agents aimed at combating diabetes and its associated complications.